Sharemaestro company-news research for Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NSI
India
Provisional evidence
Company news sentiment
AAREYDRUGS news sentiment
Aarey Drugs & Pharmaceuticals Limited
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
30-day score50Neutral is 50
Early balanced news score
15/100 evidence confidence
100% direct company focus
2 current stories across 2 publishers
Current company news
Early balanced news score
2 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Observed headline tone50/100
→
Published 30-day score50/100
Latest source headline
Aarey Drugs Allots 25.2 Lakh Shares for ₹12 Crore from Warrants
Whalesbook · 06 Aug 2026 12:40 · Source lookup
Older, less relevant and less reliable stories count for less. Confidence is shown separately.
What supports the score
2 current stories are mapped specifically to AAREYDRUGS.
What limits the score
Only 2 publishers currently contribute to the measured read.
The stories agree, but freshness-weighted evidence is only 0.005.
Confidence is 15/100, below the threshold for a firm score.
50/100
News scoreEarly balanced news score
15/100
Confidencethin evidence
100%/100
Company news2 company stories
100/100
Story agreement0/100 difference
News history
Daily score and story count over 30 days
15 Jul30 Jul13 Aug
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence0
0.005 after freshness weightingSource breadth40
2 independent publishersCompany relevance100
share tied directly to this companyFreshness26
recency-weighted evidenceAgreement100
how closely stories agreePublisher mix25
less reliance on one publisherPrice and news history
News score and weekly price over 26 weeks
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
07 Aug 202650INR 81.47+4.6%
31 Jul 202650INR 77.86+0.5%
24 Jul 202650INR 77.5+3.5%
17 Jul 202650INR 74.9-9.6%
10 Jul 202650INR 82.83-2.4%
03 Jul 202650INR 84.87-8.2%
26 Jun 202650INR 92.5+10.6%
Provisional evidence
News subjects
What is shaping the score
Market update502 stories · 100%
Source mix
Where the evidence comes from
Whalesbook501 stories · 50%
MarketsMojo501 stories · 50%
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
22 Jun50 neutral13 Aug 20:05
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 13 Aug 20:05 | 50 | +0 | 15/100 (-10) | 2 (0) | Provisional |
| 06 Aug 23:59 | 50 | +0 | 25/100 (-1) | 2 (0) | Provisional |
| 01 Aug 23:59 | 50 | +0 | 26/100 (0) | 2 (0) | Provisional |
| 05 Jul 23:59 | 50 | +1 | 26/100 (-2) | 2 (+1) | Provisional |
| 22 Jun 23:59 | 49 | Start | 28/100 | 1 | Provisional |
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
#150Tone
WhalesbookDirect company coverageScored from headlineSource lookup
Aarey Drugs Allots 25.2 Lakh Shares for ₹12 Crore from Warrants
- Published
- 06 Aug 2026 12:40
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- High · 85.2% · 7.3d old
- Duplicates
- 2 consolidated
#250Tone
MarketsMojoDirect company coverageScored from headlineSource lookup
Aarey Drugs & Pharmaceuticals Ltd is Rated Hold
- Published
- 01 Aug 2026 11:26
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Medium · 14.8% · 12.4d old
- Duplicates
- 1 consolidated
Earlier company news
AAREYDRUGS news archive
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
Older news is kept in the archive
There are 2 older AAREYDRUGS headlines. Open one page at a time when you need them.
Open older archiveHow the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.